| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |